MannKind

+$0.08 (+1.98%) Today
-$0.01 (-0.24%) As of 8:05 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

CEO
Michael E. Castagna
Employees
349
Headquarters
Danbury, Connecticut
Founded
1991

MNKD Key Statistics

Market cap
1.04B
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.27M
High today
$4.37
Low today
$4.01
Open price
$4.01
Volume
5.51M
52 Week high
$5.44
52 Week low
$2.49

MNKD News

Simply Wall St21h

Insiders of MannKind Corporation are up 48% on their US$750k purchase after MannKind Corporation rose 6.9% last week - Simply Wall St

Insiders who bought MannKind Corporation ( ) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$66m as a res

MNKD Earnings

-$0.11
-$0.07
-$0.04
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure